|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0029463,
umls-concept:C0030705,
umls-concept:C0085415,
umls-concept:C0185117,
umls-concept:C0392752,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1367028,
umls-concept:C1552599,
umls-concept:C1704787,
umls-concept:C2911684
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2011-3-3
|
|
pubmed:abstractText |
The receptor activator of nuclear factor ?B ligand (RANKL/TNFSF11) is expressed in metastatic bone cancer cells and has been suggested to play a key role in cell migration and metastatic behavior. We determined whether RANKL expression is correlated to clinical behavior of localized, high-grade osteosarcoma.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1545-5017
|
|
pubmed:author |
pubmed-author:ChoWan HyeongWH,
pubmed-author:JeonDae-GeunDG,
pubmed-author:JungJun SooJS,
pubmed-author:KimDong HoDH,
pubmed-author:KimMin SukMS,
pubmed-author:KohJae-SooJS,
pubmed-author:KongChang-BaeCB,
pubmed-author:LeeJun AhJA,
pubmed-author:LeeSoo-YongSY,
pubmed-author:LimJung SubJS,
pubmed-author:SongWon SeokWS
|
|
pubmed:copyrightInfo |
Copyright © 2011 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
56
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
738-43
|
|
pubmed:meshHeading |
pubmed-meshheading:21370405-Adolescent,
pubmed-meshheading:21370405-Adult,
pubmed-meshheading:21370405-Aged,
pubmed-meshheading:21370405-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21370405-Bone Neoplasms,
pubmed-meshheading:21370405-Child,
pubmed-meshheading:21370405-Child, Preschool,
pubmed-meshheading:21370405-Female,
pubmed-meshheading:21370405-Humans,
pubmed-meshheading:21370405-Immunoenzyme Techniques,
pubmed-meshheading:21370405-Male,
pubmed-meshheading:21370405-Middle Aged,
pubmed-meshheading:21370405-Neoplasm Staging,
pubmed-meshheading:21370405-Osteosarcoma,
pubmed-meshheading:21370405-Prognosis,
pubmed-meshheading:21370405-RANK Ligand,
pubmed-meshheading:21370405-Retrospective Studies,
pubmed-meshheading:21370405-Survival Rate,
pubmed-meshheading:21370405-Treatment Outcome,
pubmed-meshheading:21370405-Tumor Markers, Biological,
pubmed-meshheading:21370405-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
RANKL expression is related to treatment outcome of patients with localized, high-grade osteosarcoma.
|
|
pubmed:affiliation |
Department of Pediatrics, Korea Cancer Center Hospital, Seoul, Republic of Korea.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
